Pharmacological strategies for lowering LDL cholesterol: statins and beyond

被引：0
|
作者：
Ariel Brautbar
Christie M. Ballantyne
机构：
[1] Section of Cardiovascular Research,Department of Medicine
[2] Baylor College of Medicine,undefined
[3] Methodist DeBakey Heart and Vascular Center,undefined
来源：
Nature Reviews Cardiology | 2011年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The relationship between an elevated level of LDL cholesterol (LDL-C) and increased risk of cardiovascular disease is well established. National and international guidelines are continuously being revised to recommend increasingly lower LDL-C targets for cardiovascular disease prevention. In this Review, Drs. Brautbar and Ballantyne examine the evidence and recommendations for optimal LDL-C levels and the agents currently available or under development to achieve these levels.
引用
收藏
页码：253 / 265
页数：12
相关论文
共 50 条
12345